Near‐infrared fluorescence‐labeled anti‐PD‐L1‐mAb for tumor imaging in human colorectal cancer xenografted mice

The expression of programmed death ligand‐1 (PD‐L1) in tumor has been used as a biomarker to predict the anti‐PD‐L1 immunotherapy response. To develop a noninvasive imaging technique to monitor the dynamic changes in PD‐L1 expression in colorectal cancer (CRC), we labeled an anti‐PD‐L1 monoclonal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mingyu, Jiang, Huijie, Zhang, Rongjun, Jiang, Hao, Xu, Hailong, Pan, Wenbin, Gao, Xiaolin, Sun, Zhongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590288/
https://www.ncbi.nlm.nih.gov/pubmed/30609118
http://dx.doi.org/10.1002/jcb.28308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590288/
https://www.ncbi.nlm.nih.gov/pubmed/30609118
http://dx.doi.org/10.1002/jcb.28308

Ejemplares similares